OncoVista Innovative Therapies, Inc. Stock
Equities
OVIT
US68232J1051
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | +9,900.00% |
Sales 2013 | - | Sales 2014 | - | Capitalization | 1.3M 1.78M |
---|---|---|---|---|---|
Net income 2013 | -1M -1.37M | Net income 2014 | -2M -2.74M | EV / Sales 2013 | - |
Net cash position 2013 | 44.9K 61.45K | Net Debt 2014 | 196K 268K | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.75
x | P/E ratio 2014 |
-0.51
x | Employees | 2 |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 2.36K | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- OVIT Stock